Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
INGN Inogen	$7.70 +1.6%	$6.75	$5.70 ▼ $13.33	$204.97M	1.72	279,417 shs	319,075 shs
POSC Positron	$1.79 +2.4%	$1.59	$0.92 ▼ $2.94	$54.90M	0.43	30,339 shs	2,734 shs
PROF Profound Medical	$5.45 -2.0%	$5.94	$3.89 ▼ $9.87	$167.10M	0.52	28,764 shs	11,077 shs
STXS Stereotaxis	$2.70 +1.5%	$2.27	$1.54 ▼ $2.72	$228.76M	1.51	774,149 shs	701,419 shs

7 Stocks to Buy And Hold Forever

Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
INGN Inogen	+7.67%	+19.75%	+9.54%	+28.91%	-35.71%
POSC Positron	+0.69%	+5.62%	+18.11%	+20.55%	+58.91%
PROF Profound Medical	-1.24%	-0.36%	-4.30%	+37.62%	-35.94%
STXS Stereotaxis	+4.72%	+18.75%	+18.22%	+30.39%	+42.25%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
INGN Inogen	4.001 of 5 stars	3.3	3.0	3.9	2.1	1.7	0.6
POSC Positron	0.0923 of 5 stars	0.0	3.0	0.0	0.0	0.8	0.0
PROF Profound Medical	2.4919 of 5 stars	3.5	1.0	0.0	2.9	2.5	0.6
STXS Stereotaxis	0.1524 of 5 stars	0.0	0.0	0.0	1.6	1.7	0.6

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
INGN Inogen	2.50	Moderate Buy	$11.00	42.86% Upside
POSC Positron	0.00	N/A	N/A	N/A
PROF Profound Medical	3.00	Buy	$11.00	101.83% Upside
STXS Stereotaxis	0.00	N/A	N/A	N/A

Current Analyst Ratings Breakdown

Latest POSC, PROF, INGN, and STXS Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
6/16/2025	INGN Inogen	B. Riley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Buy	$14.00
6/15/2025	INGN Inogen	B. Riley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Buy	$14.00
5/22/2025	INGN Inogen	Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Hold ➝ Moderate Buy	$12.00

(Data available from 8/13/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
INGN Inogen	$335.70M	0.62	N/A	N/A	$7.38 per share	1.04
POSC Positron	$590K	95.29	N/A	N/A	($0.04) per share	-44.75
PROF Profound Medical	$10.68M	15.33	N/A	N/A	$2.01 per share	2.71
STXS Stereotaxis	$26.92M	8.63	N/A	N/A	$0.07 per share	38.57

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
INGN Inogen	-$35.89M	-$1.06	N/A	N/A	N/A	-7.58%	-13.77%	-8.52%	N/A
POSC Positron	-$2.39M	-$0.12	N/A	∞	N/A	-592.35%	N/A	-116.31%	N/A
PROF Profound Medical	-$27.82M	-$1.22	N/A	N/A	N/A	-269.35%	-70.41%	-57.22%	8/14/2025 (Estimated)
STXS Stereotaxis	-$24.05M	-$0.28	N/A	N/A	N/A	-73.43%	-354.30%	-48.87%	N/A

Latest POSC, PROF, INGN, and STXS Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/14/2025	Q2 2025	PROF Profound Medical	-$0.43	N/A	N/A	N/A	$4.75 million	N/A
8/7/2025	Q2 2025	INGN Inogen	-$0.22	-$0.15	+$0.07	-$0.15	$90.40 million	$92.28 million
5/15/2025	Q1 2025	POSC Positron	N/A	-$0.05	N/A	-$0.05	N/A	$0.12 million

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
INGN Inogen	N/A	N/A	N/A	N/A	N/A
POSC Positron	N/A	N/A	N/A	N/A	N/A
PROF Profound Medical	N/A	N/A	N/A	N/A	N/A
STXS Stereotaxis	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
INGN Inogen	N/A	3.03	2.67
POSC Positron	N/A	2.69	2.04
PROF Profound Medical	0.09	11.31	10.03
STXS Stereotaxis	N/A	1.07	0.66

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
INGN Inogen	89.94%
POSC Positron	N/A
PROF Profound Medical	47.86%
STXS Stereotaxis	45.35%

Insider Ownership

Company	Insider Ownership
INGN Inogen	1.46%
POSC Positron	17.20%
PROF Profound Medical	1.52%
STXS Stereotaxis	17.77%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
INGN Inogen	1,030	27.04 million	26.65 million	Optionable
POSC Positron	20	31.41 million	26.00 million	Not Optionable
PROF Profound Medical	150	30.05 million	29.60 million	Optionable
STXS Stereotaxis	130	86.00 million	70.72 million	Not Optionable

POSC, PROF, INGN, and STXS Headlines

Recent News About These Companies

Stereotaxis, Inc. (STXS) Q2 2025 Earnings Call Transcript

August 8, 2025 | seekingalpha.com

Stereotaxis Inc. (STXS) Reports Q2 Loss, Tops Revenue Estimates

August 7, 2025 | zacks.com

Stereotaxis Reports 2025 Second Quarter Financial Results

August 7, 2025 | globenewswire.com

Warberg Asset Management LLC Acquires 275,784 Shares of Stereotaxis Inc. (NYSEAMERICAN:STXS)

August 4, 2025 | marketbeat.com

Will Stereotaxis Inc. (STXS) Report Negative Earnings Next Week? What You Should Know

July 31, 2025 | zacks.com

Stereotaxis (STXS) to Release Earnings on Thursday

July 31, 2025 | marketbeat.com

Stereotaxis (STXS) Gets a Buy from TD Cowen

July 30, 2025 | theglobeandmail.com

Essex Investment Management Co. LLC Buys 343,130 Shares of Stereotaxis Inc. (NYSEAMERICAN:STXS)

July 29, 2025 | marketbeat.com

Stereotaxis, Inc.: Stereotaxis Receives U.S. FDA Clearance for MAGiC Sweep Catheter

July 28, 2025 | finanznachrichten.de

Stereotaxis Wins FDA Nod for Catheter

July 28, 2025 | baystreet.ca

Stereotaxis stock soars after FDA clearance for robotic mapping catheter

July 28, 2025 | za.investing.com

Stereotaxis gets FDA green light for robotic electrophysiology mapping catheter

July 28, 2025 | massdevice.com

Stereotaxis shares jump after FDA approves robotic mapping catheter

July 28, 2025 | msn.com

Stereotaxis Receives U.S. FDA Clearance for MAGiC Sweep Catheter

July 28, 2025 | globenewswire.com

Stereotaxis to Report Second Quarter 2025 Financial Results on August 7, 2025

July 23, 2025 | globenewswire.com

Stereotaxis (NYSEAMERICAN:STXS) Stock Price Down 2.5% - What's Next?

July 19, 2025 | marketbeat.com

Stereotaxis announces $12.5M offering

July 18, 2025 | massdevice.com

Stereotaxis Sinks on Common Stock Offering

July 17, 2025 | baystreet.ca

Stereotaxis Announces $12.5 Million Registered Direct Offering of Common Stock

July 17, 2025 | globenewswire.com

Stereotaxis, Inc. (STXS) - Yahoo Finance

July 10, 2025 | finance.yahoo.com

Stereotaxis Publishes Positive Results from MAGiC Catheter Study

July 10, 2025 | msn.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

POSC, PROF, INGN, and STXS Company Descriptions

Inogen NASDAQ:INGN

$7.70 +0.12 (+1.58%)

Closing price 04:00 PM Eastern

Extended Trading

$7.70 0.00 (-0.06%)

As of 07:11 PM Eastern

Inogen, Inc., a medical technology company, develops, manufactures, and markets portable oxygen concentrators to patients, physicians and other clinicians, and third-party payors in the United States and internationally. Its oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. The company offers Inogen One, a portable device that concentrate the air around the patient to provide a source of supplemental oxygen; Inogen At Home stationary oxygen concentrators; Simeox airway clearance; batteries; and related accessories. It also rents its products directly to patients. Inogen, Inc. was incorporated in 2001 and is headquartered in Goleta, California.

Positron OTCMKTS:POSC

$1.79 +0.04 (+2.40%)

As of 03:29 PM Eastern

Positron Corporation, a nuclear medicine healthcare company, specializes in the business of cardiac positron emission tomography (PET) imaging in the United States. It offers attrius PET scanner, clinical and technical services, and financing solutions enables healthcare providers to accurately diagnose cardiac disease, improve patient outcomes, and practice cost effective medicines. Positron Corporation was incorporated in 1983 and is based in Niagara Falls, New York.

Profound Medical NASDAQ:PROF

$5.45 -0.11 (-1.98%)

Closing price 04:00 PM Eastern

Extended Trading

$5.50 +0.05 (+1.01%)

As of 04:10 PM Eastern

Profound Medical Corp., together with its subsidiaries, operates as a commercial-stage medical device company that develops and markets incision-free therapeutic systems for the image guided ablation of diseased tissue in Canada, Germany, the United States, and Finland. Its lead product TULSA-PRO system combines magnetic resonance imaging(MRI), robotically-driven transurethral sweeping action/thermal ultrasound and closed-loop temperature feedback control to provide precise, flexible, and durable ablation of a surgeon defined region of prostate and protect the urethra and rectum. The company also offers Sonalleve, which combines real-time MRI and thermometry for the treatment of uterine fibroids, adenomyotic tissue, palliative pain treatment of bone metastases, osteoid osteoma, and management of benign tumors. Profound Medical Corp. is headquartered in Mississauga, Canada.

Stereotaxis NYSEAMERICAN:STXS

$2.70 +0.04 (+1.50%)

Closing price 04:10 PM Eastern

Extended Trading

$2.64 -0.07 (-2.41%)

As of 04:55 PM Eastern

Stereotaxis, Inc. designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally. Its robotic magnetic navigation (RMN) systems include the Genesis RMN and Niobe systems, which enable physicians to complete complex interventional procedures by providing image-guided delivery of catheters and guidewires through the blood vessels and chambers of the heart to treatment sites. The company provides Odyssey, a real-time information solution to manage, control, record, and share procedures across networks; and Stereotaxis Imaging Model S X-ray system, a single-plane, full-power x-ray system, including c-arm, powered table, motorized boom, and monitors for a robotic interventional operating room. In addition, it offers disposables and other accessories, such as QuikCAS automated catheter advancement disposables for the remote advancement of electrophysiology catheters. Further, the company provides Vdrive, a system that offers navigation and stability for the diagnostic and therapeutic devices designed to improve interventional procedures; and V-Loop, V-Sono, and V-CAS disposable components. It markets its products through direct sales force, distributors, and sales agents. The company has a strategic collaboration with MAGiC catheter for cardiac ablation procedures. Stereotaxis, Inc. was incorporated in 1990 and is based in Saint Louis, Missouri.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time